Sign Up to like & get
recommendations!
1
Published in 2020 at "Neurosurgery clinics of North America"
DOI: 10.1016/j.nec.2019.11.003
Abstract: Innovation in surgical technique and contemporary spinal instrumentation paired with intraoperative navigation/imaging concepts allows for safer and less-invasive surgical approaches. The combination of stereotactic body radiotherapy, contemporary surgical adjuncts, and less-invasive techniques serves to minimize…
read more here.
Keywords:
invasive surgery;
minimally invasive;
strategies changing;
treatment ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2019 at "Blood advances"
DOI: 10.1182/bloodadvances.2019000937
Abstract: Venetoclax is a specific B-cell lymphoma-2 (BCL-2) inhibitor that can restore activation of apoptosis in malignancies, the survival of which depends on dysregulation of this pathway. Preclinical data, using various model systems including cell lines…
read more here.
Keywords:
venetoclax;
venetoclax aml;
treatment paradigm;
changing treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Current cancer drug targets"
DOI: 10.2174/156800962008200714125648
Abstract:
read more here.
Keywords:
myeloid leukemia;
leukemia changing;
changing treatment;
treatment paradigms ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16010102
Abstract: In the West, recent decades have demonstrated an epidemiological trend towards esophago-gastric adenocarcinomas (EGAC), with considerable associated mortality. Historically, chemotherapy has represented the sole systemic treatment option in the advanced EGAC setting, in addition to…
read more here.
Keywords:
changing treatment;
checkpoint inhibitors;
immune checkpoint;
treatment landscape ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2018.0051
Abstract: Urothelial carcinoma is the predominant histologic type of bladder cancer. After 30 years of minimal progress in the treatment of advanced-stage disease, recent advances in the genomic characterization of urothelial cancer and breakthroughs in bladder…
read more here.
Keywords:
carcinoma;
treatment landscape;
changing treatment;
urothelial carcinoma ... See more keywords